BOOK
Controversies in Spinal and Cranial Surgery, An Issue of Neurosurgery Clinics of North America, E-Book
Russell R. Lonser | Daniel K. Resnick
(2017)
Additional Information
Book Details
Abstract
This issue of Neurosurgery Clinics focuses on Controversies in Spinal and Cranial Surgery. Article topics will include:Sacro-illiac Fusion; Interspinous Spacers;Bone Morphogenetic Protein, Platelet Concentrates and Other Biologics; MIS decompression; Pipeline flow diversion in subarachnoid hemorrhage; Direct versus indirect bypass for moyamoya disease; Management of prenatally diagnosed myelomeningocele; Management of incidental aneurysm; Surgical management of incidental low-grade glioma; and more!
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Controversies in Spinaland Cranial Surgery\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITORS | iii | ||
| EDITORS | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Preface: Current Controversies in Spinal and Cranial Surgery | vii | ||
| Spinal Surgery | vii | ||
| The Sacroiliac Joint\r | vii | ||
| Sacroiliac Fusion: Another “Magic Bullet” Destined for Disrepute\r | vii | ||
| Is There Still a Role for Interspinous Spacers in the Management of Neurogenic Claudication?\r | vii | ||
| Bone Morphogenic Protein Use in Spinal Surgery\r | vii | ||
| Lumbar Radiculopathy in the Setting of Degenerative Scoliosis: MIS Decompression and Limited Correction are Better Options\r | viii | ||
| The Case for Deformity Correction in the Management of Radiculopathy with Concurrent Spinal Deformity\r | viii | ||
| Cranial Surgery\r | viii | ||
| Hemicraniectomy for Ischemic and Hemorrhagic Stroke: Facts and Controversies\r | viii | ||
| Direct Versus Indirect Bypass for Moyamoya Disease\r | viii | ||
| Flow Diversion after Aneurysmal Subarachnoid Hemorrhage\r | ix | ||
| Management of Small Incidental Intracranial Aneurysms\r | ix | ||
| Surgical Management of Incidental Gliomas\r | ix | ||
| Reoperation for Recurrent Glioblastoma Multiforme\r | ix | ||
| Surgical Treatment of Trigeminal Neuralgia\r | x | ||
| Comparison of Prenatal and Postnatal Management of Patients with Myelomeningocele\r | x | ||
| NEUROSURGERY CLINICS OF NORTH AMERICA\r | xi | ||
| FORTHCOMING ISSUES | xi | ||
| October 2017 | xi | ||
| January 2018 | xi | ||
| RECENT ISSUES | xi | ||
| April 2017 | xi | ||
| January 2017 | xi | ||
| Preface\r | xiii | ||
| Current Controversies in Spinal and Cranial Surgery | xiii | ||
| The Sacroiliac Joint | 301 | ||
| Key points | 301 | ||
| REFERENCES | 311 | ||
| Sacroiliac Fusion | 313 | ||
| Key points | 313 | ||
| INTRODUCTION | 313 | ||
| EPIDEMIOLOGY | 313 | ||
| ANATOMY | 314 | ||
| POTENTIAL CAUSES OF SACROILIAC JOINT PAIN | 315 | ||
| DIAGNOSIS | 315 | ||
| TREATMENT | 316 | ||
| SUMMARY | 318 | ||
| ACKNOWLEDGMENTS | 318 | ||
| REFERENCES | 318 | ||
| Is There Still a Role for Interspinous Spacers in the Management of Neurogenic Claudication? | 321 | ||
| Key points | 321 | ||
| INTRODUCTION | 321 | ||
| INTERSPINOUS SPACER DEVELOPMENT | 322 | ||
| SURGICAL VERSUS NONSURGICAL MANAGEMENT OF LUMBAR SPINAL STENOSIS | 322 | ||
| CONFLICTING EVIDENCE FOR INTERSPINOUS SPACER USE | 323 | ||
| INDICATIONS FOR INTERSPINOUS SPACER USE | 324 | ||
| SURGICAL TECHNIQUE/PROCEDURE | 325 | ||
| SURGICAL COMPLICATIONS AND MANAGEMENT | 325 | ||
| FUTURE DIRECTIONS AND CONSENSUS STATEMENT | 325 | ||
| SUMMARY | 328 | ||
| REFERENCES | 328 | ||
| Bone Morphogenic Protein Use in Spinal Surgery | 331 | ||
| Key points | 331 | ||
| INTRODUCTION | 331 | ||
| DEVELOPMENT OF BONE MORPHOGENIC PROTEIN | 332 | ||
| CONTROVERSY SURROUNDING BONE MORPHOGENIC PROTEIN USE | 332 | ||
| THE CURRENT USE OF BONE MORPHOGENIC PROTEIN | 333 | ||
| SUMMARY | 334 | ||
| ACKNOWLEDGMENTS | 334 | ||
| REFERENCES | 334 | ||
| Lumbar Radiculopathy in the Setting of Degenerative Scoliosis | 335 | ||
| Key points | 335 | ||
| INTRODUCTION | 335 | ||
| CASE EXAMPLE | 336 | ||
| TREATMENT RATIONALE AND DISCUSSION | 337 | ||
| SUMMARY | 339 | ||
| REFERENCES | 339 | ||
| The Case for Deformity Correction in the Management of Radiculopathy with Concurrent Spinal Deformity | 341 | ||
| Key points | 341 | ||
| INTRODUCTION | 341 | ||
| The Relationship Between Deformity and Symptomatic Radiculopathy | 342 | ||
| VARIABILITY IN APPROACHES TO CARE | 342 | ||
| DECOMPRESSION ALONE | 342 | ||
| DECOMPRESSION WITH LIMITED FUSION | 343 | ||
| DECOMPRESSION WITH EXTENSIVE FUSION | 344 | ||
| SUMMARY | 345 | ||
| REFERENCES | 345 | ||
| Hemicraniectomy for Ischemic and Hemorrhagic Stroke | 349 | ||
| Key points | 349 | ||
| INTRODUCTION | 350 | ||
| ISCHEMIC HEMISPHERIC STROKE (SUPRATENTORIAL) | 350 | ||
| Epidemiology | 350 | ||
| Pathophysiology of Malignant Stroke | 350 | ||
| Microscopic and cellular changes | 350 | ||
| Macroscopic pathology | 350 | ||
| Predictors of Progression | 350 | ||
| Time since stroke | 350 | ||
| National Institutes of Health stroke scale | 351 | ||
| Computed tomography | 351 | ||
| MRI | 351 | ||
| Best Medical Management | 351 | ||
| Data on Decompressive Craniectomy Before Randomized Controlled Trials | 351 | ||
| Data from Randomized Controlled Trials on Hemicraniectomy for Malignant Ischemic Stroke | 352 | ||
| Study design | 352 | ||
| Results of the randomized controlled trials | 352 | ||
| Effects on mortality (MRS 6) | 352 | ||
| Effects on moderately severe disability (MRS 4) | 352 | ||
| Effects on severe disability (MRS 5) | 353 | ||
| Effect on MRS 0 to 3 (good outcome) | 353 | ||
| Effect of timing of surgery on outcome | 353 | ||
| Dominant hemisphere involvement | 353 | ||
| Additional evidence | 353 | ||
| Limitations of the randomized controlled trials | 353 | ||
| Surgical Technique | 354 | ||
| Postoperative Management | 354 | ||
| Complications of Decompressive Craniectomy | 354 | ||
| Decompressive Craniectomy for Malignant Middle Cerebral Artery Stroke: A Case Illustration | 354 | ||
| ISCHEMIC POSTERIOR FOSSA STROKE (INFRATENTORIAL) | 354 | ||
| Existing Evidence | 355 | ||
| Surgical Technique | 356 | ||
| Decompressive Craniectomy for Posterior Fossa Ischemic Stroke: A Case Illustration | 356 | ||
| HEMORRHAGIC STROKE | 356 | ||
| Overview of Intracerebral Hemorrhage | 356 | ||
| Pathophysiology of Spontaneous Intracerebral Hemorrhage | 356 | ||
| Decompressive Craniectomy for Supratentorial Intracerebral Hemorrhage | 357 | ||
| Decompressive Craniectomy for Hemorrhagic Stroke: A Case Illustration | 357 | ||
| Decompressive Craniectomy for Posterior Fossa Hemorrhage | 357 | ||
| STATE OF CURRENT KNOWLEDGE AND FUTURE TRIAL AREAS | 358 | ||
| ACKNOWLEDGMENTS | 358 | ||
| REFERENCES | 358 | ||
| Direct Versus Indirect Bypass for Moyamoya Disease | 361 | ||
| Key points | 361 | ||
| INTRODUCTION | 361 | ||
| PATIENT EVALUATION OVERVIEW | 362 | ||
| NONSURGICAL TREATMENT OPTIONS | 362 | ||
| SURGICAL TREATMENT OPTIONS | 362 | ||
| Direct Bypass Technique | 362 | ||
| Indirect Bypass Techniques | 365 | ||
| INDIRECT TECHNIQUES USING DISTANT TISSUE | 367 | ||
| DISCUSSION | 370 | ||
| Benefits of Revascularization | 370 | ||
| Direct Versus Indirect Bypass and Outcomes | 370 | ||
| SUMMARY | 372 | ||
| REFERENCES | 373 | ||
| Flow Diversion after Aneurysmal Subarachnoid Hemorrhage | 375 | ||
| Key points | 375 | ||
| INTERNATIONAL SUBARACHNOID ANEURYSM TRIAL ESTABLISHED ENDOVASCULAR TREATMENT AS THE PRIMARY TREATMENT OF RUPTURED ANEURYSMS | 375 | ||
| WHO GETS CLIPPED AFTER THE INTERNATIONAL SUBARACHNOID ANEURYSM TRIAL? | 376 | ||
| ENDOVASCULAR DEVICES ARE DEVELOPING AT A RAPID PACE TO ENABLE TREATMENT OF MORE COMPLEX ANEURYSM MORPHOLOGIES AND TO DECREA ... | 376 | ||
| OUR PROTOCOL FOR ANEURYSMAL SUBARACHNOID HEMORRHAGE | 376 | ||
| WHAT IS FLOW DIVERSION? | 377 | ||
| FLOW DIVERSION IS NOT THE PREFERRED TREATMENT AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE | 377 | ||
| PATIENT SELECTION FOR FLOW DIVERSION AFTER ANEURYSMAL SUBARACHNOID HEMORRHAGE | 377 | ||
| ANTIPLATELET THERAPY | 377 | ||
| FLOW-DIVERSION TECHNIQUE | 377 | ||
| OUR EXPERIENCE WITH FLOW DIVERSION AFTER SUBARACHNOID HEMORRHAGE | 378 | ||
| REVIEW OF THE LITERATURE | 381 | ||
| Hemorrhagic Risk with Dual Antiplatelet Agents After Subarachnoid Hemorrhage | 385 | ||
| Blister Aneurysms | 385 | ||
| Risk of Dome Protection and Delayed Flow Diversion After Aneurysmal Rupture | 385 | ||
| Flow Diversion Is Associated with Better Long-term Aneurysm Occlusion Rates | 386 | ||
| Coiling-assisted Flow Diversion | 386 | ||
| SHIELD TECHNOLOGY MAY INCREASE THE SAFETY OF FLOW DIVERSION IN ANEURYSMAL SUBARACHNOID HEMORRHAGE | 386 | ||
| SUMMARY | 386 | ||
| DISCLOSURE | 386 | ||
| REFERENCES | 387 | ||
| Management of Small Incidental Intracranial Aneurysms | 389 | ||
| Key points | 389 | ||
| INTRODUCTION | 389 | ||
| PATIENT EVALUATION OVERVIEW | 389 | ||
| MEDICAL TREATMENT OPTIONS | 392 | ||
| SURGICAL TREATMENT OPTIONS | 392 | ||
| EVALUATION OF OUTCOME AND LONG-TERM RECOMMENDATIONS | 393 | ||
| SUMMARY/DISCUSSION | 395 | ||
| REFERENCES | 395 | ||
| Surgical Management of Incidental Gliomas | 397 | ||
| Key points | 397 | ||
| INTRODUCTION | 397 | ||
| GLIOMA GENETICS | 398 | ||
| DIAGNOSTIC IMAGING | 398 | ||
| STEREOTACTIC BIOPSY | 399 | ||
| MICROSURGICAL RESECTION | 399 | ||
| FUNCTIONAL MAPPING | 401 | ||
| MALIGNANT TRANSFORMATION | 402 | ||
| ADVANCED TECHNOLOGIES | 403 | ||
| SUMMARY | 403 | ||
| REFERENCES | 403 | ||
| Reoperation for Recurrent Glioblastoma Multiforme | 407 | ||
| Key points | 407 | ||
| INTRODUCTION | 407 | ||
| METHODS | 408 | ||
| RESULTS | 408 | ||
| DISCUSSION | 409 | ||
| Inclusion and Exclusion Criteria | 409 | ||
| Indications for Surgery | 414 | ||
| Survival Following Reoperation for Recurrent or Progressive Glioblastoma Multiforme | 414 | ||
| Extent of resection | 424 | ||
| Progression-free survival | 424 | ||
| Complications | 424 | ||
| Bias | 425 | ||
| SUMMARY | 425 | ||
| ACKNOWLEDGMENTS | 425 | ||
| REFERENCES | 425 | ||
| Surgical Treatment of Trigeminal Neuralgia | 429 | ||
| Key points | 429 | ||
| INTRODUCTION | 429 | ||
| MICROVASCULAR DECOMPRESSION | 429 | ||
| Success Rates | 429 | ||
| Complications | 430 | ||
| PERCUTANEOUS TREATMENTS | 431 | ||
| Percutaneous Radiofrequency Rhizotomy | 431 | ||
| Success rates | 431 | ||
| Complications | 431 | ||
| Percutaneous Glycerol Rhizotomy | 432 | ||
| Comparison of Prenatal and Postnatal Management of Patients with Myelomeningocele | 439 | ||
| Key points | 439 | ||
| INTRODUCTION | 439 | ||
| POSTNATAL REPAIR OF MYELOMENINGOCELE | 440 | ||
| PRENATAL DIAGNOSIS OF MYELOMENINGOCELE | 441 | ||
| Prenatal Imaging Assessment: Fetal MRI | 443 | ||
| PRENATAL REPAIR OF MYELOMENINGOCELE | 443 | ||
| Outcomes of Postnatal Versus Prenatal Myelomeningocele Correction | 444 | ||
| Future Perspectives of Myelomeningocele Treatment | 446 | ||
| SUMMARY | 447 | ||
| REFERENCES | 447 | ||
| Index | 449 |